TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) just unveiled an announcement.
Clarity Pharmaceuticals Ltd. has announced that JPMorgan Chase & Co. and its affiliates have ceased to be substantial holders in the company. This change in holdings involves various transactions by JPMorgan’s subsidiaries, including securities on loan, securities received as collateral, and purchases and sales of securities. The cessation of JPMorgan as a substantial holder may impact Clarity Pharmaceuticals’ shareholder composition and market perception, potentially influencing investor sentiment and the company’s stock performance.
The most recent analyst rating on (AU:CU6) stock is a Hold with a A$5.00 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Average Trading Volume: 3,125,897
Technical Sentiment Signal: Buy
Current Market Cap: A$1.8B
For detailed information about CU6 stock, go to TipRanks’ Stock Analysis page.